{"id":"W2050501917","doi":"10.1111/jdv.12996","title":"Improvement of scalp and nail lesions with ixekizumab in a phase 2 trial in patients with chronic plaque psoriasis","year":2015,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":80,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University","funders":"Eli Lilly and Company","keywords":"Medicine; Ixekizumab; Plaque psoriasis; Dermatology; Scalp; Psoriasis; Nail (fastener); Psoriatic arthritis; Secukinumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004245659,0.0001665225,0.0006096541,0.0002499134,0.00004414016,0.000002032162,0.0002190685,0.0001928765,0.000007078271],"category_scores_gemma":[0.00005262611,0.00009637926,0.00005124361,0.0001428965,0.0005257207,0.00008065545,0.0001032969,0.0003867964,0.000001486421],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003608305,"about_ca_system_score_gemma":0.0001178006,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000126205,"about_ca_topic_score_gemma":0.00003225202,"domain_scores_codex":[0.9980112,0.0009020617,0.0006464235,0.000160206,0.00005463061,0.0002255253],"domain_scores_gemma":[0.9989864,0.0001302314,0.0006920039,0.0001006253,0.00005067547,0.00004002404],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1200714,0.002101201,0.8058448,0.00009862961,0.0009699603,0.000131769,0.001543617,0.00005264646,0.003699585,0.0006110628,0.0004872326,0.06438815],"study_design_scores_gemma":[0.3609705,0.004835782,0.6090429,0.000318075,0.0005129898,0.001893667,0.0002646807,0.000004954311,0.01958857,0.0003356041,0.001943222,0.0002889967],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962144,0.002348722,0.000008966588,0.0008379222,0.000195236,0.000249824,0.00001128651,0.000002680838,0.0001309841],"genre_scores_gemma":[0.9995862,0.000222564,0.0000586086,0.00005645853,0.0000277063,0.00000336837,0.000003438766,0.00001184034,0.00002981433],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2408992,"threshold_uncertainty_score":0.3930233,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0179566252867597,"score_gpt":0.2474452385717072,"score_spread":0.2294886132849475,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}